Navigation Links
TARGETED GENE DELIVERY SIGNALS CANCER VACCINATION IN VIVO: Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes in Cancerous Lesions (ASCO 2008)
Date:5/27/2008

x 10e9 cfu for 2 days (Cumulative Dose: 1.00 -1.25 x 10e10 cfu).

Analysis of Safety showed that no dose-limiting toxicity was observed with this regimen, and immunoreactive GM-CSF protein was NOT detected in serum samples either during or after treatment with Reximmune-C. There was no significant alteration in hemodynamic function, bone marrow suppression, liver, kidney, or any other organ dysfunction related to the intervention. Immune-related reactions consisted of transient flu-like symptoms in two patients, redness and swelling of a tumor-infiltrated lymph node and one metastatic chest nodule, and acute flank pain in one patient with adrenal gland metastasis. Analysis of efficacy in biopsied tumor specimens revealed definitive expression of the GM-CSF transgene in cancer cells indicating effective gene delivery in vivo. Further, extensive tumor necrosis and tumor infiltrating lymphocytes (TILs) were observed within the tumors. Characterization of the recruited TILs showed CD35+ dendritic cells, CD8+ killer T cells, and CD138+ plasma B cells, with lesser amounts of CD68+ macrophages and CD20+ B cells, suggesting a relatively mature or advanced immune response. Taken together, this landmark study demonstrates (1) that the functionality of the gene delivery platform is profound; (2) the genetic constructs employed are relatively safe; and (3) the potential for a personalized cancer vaccination using this sequential gene transfer approach is now a realistic goal.

For more information about Rexin-G, Reximmune-C, on-going clinical trials in the USA and abroad, and/or Epeius pathotropic (disease-seeking) gene delivery systems, please contact Dr. Erlinda M. Gordon at egordon@epeiusbiotech.com.

*(LOGO 72dpi: Send2Press.com/mediaboom/08-0421-Epeius_72dpi.jpg)

This release was issued on behalf of the above organization by Send2Press(R), a unit of Neotrope(R). http://www.Send2Press.com


'/>"/>
SOURCE Epeius Biotechnologies
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. St. Jude Discovers Factors That Accelerate Resistance to Gleevec(TM) Targeted Therapy in Lymphoblastic Leukemia
2. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
3. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
4. Microarray Sequence Capture Speeds Large-Scale Resequencing of Targeted Genomic Regions
5. Targeted Nanoparticles Offer Promise in the Battle Against Cancer
6. ARCA Discovery Announces Data Demonstrating Potential for Bucindolol as Targeted Therapy in Heart Failure, Atrial Fibrillation, and Ventricular Arrhythmia
7. ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
8. Epeius Biotechnologies Applauds the Belated Scholarship of Their Academic Contemporaries in 2007, As Targeted Gene Therapy Comes of Age in Clinical Medicine
9. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
10. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
11. Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...PRNewswire-FirstCall/-- CryoLife,Inc. (NYSE: CRY )...ulartissueprocessingcompany,announcedtodaythatitis...tAnnualHealthCareConferenceatTheNewYorkPalaceHotel...andchiefexecutiveofficerofCryoLife,Inc.,willprovid...opmentsandhostaquestionandanswersessionat4:30p.m.E...
(Date:11/23/2009)...xas,Nov.23/PRNewswire-FirstCall/-- LexiconPharmace...-linedatafromitsPhase2clinicalstudywith LX1031 inp...IBS)willbepresentedatGASTRO2009inLondonthisweek.Re...ntinIBSsymptoms,willbepresentedbyDr. PhilipM.Brown...t,onNovember25,2009at2:30pmlocaltimeatthesessionen...
(Date:11/23/2009)...,Nov.23/PRNewswire-FirstCall/-- CumberlandPharmace...-lineresultsfromastudyevaluatingthesafetyandeffica...nhospitalizedburnpatients. ,, Statisticalsignif...verinburnpatientsoverthefirst24hoursoftreatment.Th...ddegreeburnscoveringmorethan10percenttotalbodysurf...
Breaking Medicine Technology:CryoLife to Present at 21st Annual Piper Jaffray Health Care Conference 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 3AHIP Statement on President Obamas Address to the Nation 56700 1AMA Reaction to President Obamas Address on Health System Reform 56698 1AMA Reaction to President Obamas Address on Health System Reform 56698 2River flow and temperature limit trout numbers 9858 1River flow and temperature limit trout numbers 9858 2River flow and temperature limit trout numbers 9858 3
...e body temperature, for home,and clinical use, WE...f American Scientific Resources Inc. Pink Sheets: ...(R) 5-in-1 non-contact,thermometer, is pleased to ... by the Second Children,s Clinic of the University...Thermofocus(R) measures body,temperature in infant...
... print edition of Clinical Ch... A Roche Diagnostics-sponsored,pilot study evaluat...eptide,(NT-proBNP) confirms the potential value of...he risk of cardiovascular adverse events,(CV-AE) i...atory drugs of,the COX inhibitor class., The comp...
Other Medicine Technology:Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 3Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 4
(Date:11/23/2009)...d one more than doubled chances, while both increa...HealthDay News) -- Children whose mothers smoked d...ore than double the risk of having attention-defic..., new research shows. , And with exposure to bo... soared. Children whose mothers smoked during preg...
(Date:11/23/2009)...OOPSOFHOPEKIDSTOSHOOT15MILLIONFREETHROWSIN2010WORL...NDERPLANS12-CITYU.S.TOUR&TRIPTOAFRICANEXTYEAR ...KEYOURBESTSHOT" ,, SEATTLE,Nov.23/PRNewswire-U...eadofHIV/AIDS,thousandsnationwidewilltakepartin Ho...hon.Attheheartofthemovementis15-year-old AustinGut...
(Date:11/23/2009)...NTACLARA,Calif.,Nov.23/PRNewswire-FirstCall/--NewC...ictechnologyprovider,announcedtodaythatCEO,Dr.Bran...the2ndAnnualLDMICROConferenceonThursday,December3r..., Companymanagementwillbeavailableforone-on-oneme...rd.PleasecontactBrettAimeeMaasat(646)536-7331or br...
(Date:11/23/2009)...NDIEGO,Calif.,Nov.23/PRNewswire-FirstCall/--Orexig...ncedthatfourseniorexecutiveshavejoinedtheorganizat...developmentofitsobesityfranchise.Additionstotheman...gulatoryAffairs;SuzanneMcDonald,HeadofManagedMarke...lobalContraveProgram;andWhedyWang,Ph.D,MPH,HeadofG...
(Date:11/23/2009)... Recognized as Best New Technology ...ftware , Radnor, PA (PRWE...s fastest-growing Business Intelligence (BI) softw...d with the Healthcare IT Innovation™ Award i...s flagship product, QlikView. The award was presen...
Breaking Medicine News(10 mins):Health News:Smoking During Pregnancy, Lead Exposure Raise ADHD Risk in Kids 2Health News:Smoking During Pregnancy, Lead Exposure Raise ADHD Risk in Kids 3Health News:Arizona Youth Urges Thousands to Join Him for World AIDS Day Activities In December 2Health News:Arizona Youth Urges Thousands to Join Him for World AIDS Day Activities In December 3Health News:NewCardio, Inc. to Present at 2nd Annual LD MICRO Conference 2Health News:NewCardio, Inc. to Present at 2nd Annual LD MICRO Conference 3Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 2Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 3Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 4Health News:Four Senior Executives Join Orexigen(R) Therapeutics Management Team 5Health News:QlikTech Wins Healthcare IT Innovation™ Award 2Health News:QlikTech Wins Healthcare IT Innovation™ Award 3Health News:QlikTech Wins Healthcare IT Innovation™ Award 4
...ARY, Feb. 15 /PRNewswire-FirstCall/ - The Westaim ...d December 31, 2007, it recorded a,net loss of $58...$31.8,million compared to a net loss of $50.6 mill...loss of $26.8 million, or 28,cents per share, comp...
...Bulletin (Electronic Edition), A Monthly Publicat...John R. Vaughn, Chairperson January 2008, NCD Cel...INGTON, Feb. 15 The following is the,National Cou...ov ), brings you the latest issues and news affect...
...UMBURG, Ill., Feb. 15 Canine companions have a pa... to the veterinarian,leaving cats shortchanged and...o a Special Report appearing in the Feb. 15, 2008,... as dogs,do., Pet owners, the study found, genera...
...ER, Feb. 15 Global Med Technologies(R),Inc. (OTC ...medical,information technology company, announced ...as granted 510(k) clearance for ElDorado Donor(TM)...e,product in the United States., (Logo: http://w...
...INGTON, Feb. 15 After casting himself as,a "Maver...ckstep with,President Bush, pandering to the right...deology he once denounced. On the campaign trail M...e Republicans can accept in 2008. So just who is t...
...oronto -- February 15, 2008 -- A seven-year, inter...ernative therapies such as acupuncture, neck manip...g most common neck pain than many current practice.... , Therapies such as neck collars and ultrasound...
Other Medicine News:Health News:Westaim announces 2007 year-end results 2Health News:Westaim announces 2007 year-end results 3Health News:Westaim announces 2007 year-end results 4Health News:Westaim announces 2007 year-end results 5Health News:Westaim announces 2007 year-end results 6Health News:Westaim announces 2007 year-end results 7Health News:Westaim announces 2007 year-end results 8Health News:Westaim announces 2007 year-end results 9Health News:Westaim announces 2007 year-end results 10Health News:Westaim announces 2007 year-end results 11Health News:Westaim announces 2007 year-end results 12Health News:National Council on Disability Bulletin, January 2008 2Health News:National Council on Disability Bulletin, January 2008 3Health News:National Council on Disability Bulletin, January 2008 4Health News:National Council on Disability Bulletin, January 2008 5Health News:National Council on Disability Bulletin, January 2008 6Health News:Coming to the Defense of Cats 2Health News:Global Med Technologies(R), Inc. Receives FDA 510(K) Clearance for ElDorado Donor(TM) 2Health News:Global Med Technologies(R), Inc. Receives FDA 510(K) Clearance for ElDorado Donor(TM) 3Health News:McCain Myth Buster Day 3: John McCain and Veterans' Health Care 2Health News:McCain Myth Buster Day 3: John McCain and Veterans' Health Care 3Health News:7-year neck pain study sheds light on best care 2Health News:7-year neck pain study sheds light on best care 3Health News:7-year neck pain study sheds light on best care 4
...odels. This model has a movable fixation target. T... have the patient look at a particular point insid...ph a particular area on the cornea. The magic of t... you can ascertain where on the cornea you have ph...
...O2 systems available from LumenisTM offering powe...h uncompromised performance. All units feature an ...seTM operation modes. These lasers are especially ...easily transported to multiple office sites.,...
...ith intensities up to 30W, an innovative control p... transportation, plus excellent surgical capabilit...f CO2 lasers where the traditional features of Dek... combined with innovative and specific prerequisit...
Apogee Elite Two-in-One Laser System
Medicine Products: